Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spirulinea is a French biotechnology company specializing in the cultivation of spirulina and the high-tech extraction of phycocyanin, a potent antioxidant pigment. Located in Lectoure, the company utilizes controlled cultivation systems to ensure the production of high-purity microalgae free from contaminants. Their flagship product line, marketed under the L'Or Bleu brand, features concentrated liquid phycocyanin designed for the nutraceutical, sports nutrition, and wellness markets. Spirulinea focuses on optimizing the bioavailability of algal proteins and pigments through innovative cold-extraction processes. The company serves as both a producer and a developer of algae-based health solutions, emphasizing sustainability and local production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spirulinea.